Xia Zhen, Yu Jianhua, Li Juxiang, Xiong Qinmei, Tang Yanhua, Yan Sujuan, Hong Kui, Cheng Xiaoshu
Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Department of Cardiac Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Heart Surg Forum. 2019 Mar 11;22(2):E131-E133. doi: 10.1532/hsf.2291.
Pacemaker lead-related thrombosis is a rare but severe complication in patients with pacing lead implantation in the right ventricle. We present a case with recurrent syncope after single-chamber implantable cardioverter defibrillator (ICD) implantation. Pacing lead-related thrombosis was observed during open-heart surgery. This induced intermittent pacemaker dysfunction and recurrent syncope.
A 67-year-old male patient presented with frequent episodes of syncope and a history of dilated cardiomyopathy and paroxysmal ventricular tachycardia. Normal coronary angiography was found, and therefore a single-chamber ICD was implanted into the right ventricle to prevent cardiac events in 2013. However, he was referred to our hospital because of recurrent syncope 3 to 4 years after ICD implantation. A comprehensive investigation was performed to find out the etiology for the recurrent syncope. Pacing lead thrombosis was finally observed during open-heart surgery, which can introduce intermittent pacemaker dysfunction. After the thrombus was removed and the lead was separated from the posterior leaflet of the tricuspid valve, the ICD functioned normally after reprogramming. Oral anticoagulant was prescribed after discharging. During the 1-year follow-up period, this patient was free of syncope.
This case illustrated that pacemaker lead-associated thrombosis should be considered when the cardiac implantable electronic device fails to prevent patients from having cardiac events. Oral anticoagulant might be important for preventing thrombosis among patients with ICD implantation into the right ventricle.
起搏器导线相关血栓形成是右心室植入起搏导线患者中一种罕见但严重的并发症。我们报告一例单腔植入式心脏复律除颤器(ICD)植入后反复晕厥的病例。在心脏直视手术中观察到起搏导线相关血栓形成。这导致间歇性起搏器功能障碍和反复晕厥。
一名67岁男性患者,有频繁晕厥发作史,患有扩张型心肌病和阵发性室性心动过速。冠状动脉造影正常,因此在2013年将单腔ICD植入右心室以预防心脏事件。然而,在ICD植入3至4年后,他因反复晕厥被转诊至我院。进行了全面调查以找出反复晕厥的病因。最终在心脏直视手术中观察到起搏导线血栓形成,这可导致间歇性起搏器功能障碍。血栓清除且导线与三尖瓣后叶分离后,重新编程后ICD功能恢复正常。出院后给予口服抗凝药。在1年的随访期内,该患者未再发生晕厥。
该病例表明,当心脏植入式电子装置未能预防患者发生心脏事件时,应考虑起搏器导线相关血栓形成。口服抗凝药对于预防右心室植入ICD的患者发生血栓形成可能很重要。